These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 9864076)

  • 1. Involvement of serotonin and dopamine in the mechanism of action of novel antidepressant drugs: a review.
    Bonhomme N; Esposito E
    J Clin Psychopharmacol; 1998 Dec; 18(6):447-54. PubMed ID: 9864076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonin-dopamine interaction as a focus of novel antidepressant drugs.
    Esposito E
    Curr Drug Targets; 2006 Feb; 7(2):177-85. PubMed ID: 16475959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Consequences of the monoaminergic systems cross-talk in the antidepressant activity].
    Tritschler L; Gaillard R; Gardier AM; David DJ; Guilloux JP
    Encephale; 2018 Jun; 44(3):264-273. PubMed ID: 29801770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of monoaminergic targets in the antidepressant- and anxiolytic-like effects of the synthetic alkamide riparin IV: Elucidation of further mechanisms through pharmacological, neurochemistry and computational approaches.
    Sartori DP; Oliveira NF; Valentim JT; Silva DMA; Mallman ASV; Oliveira ICM; Chaves RC; Capibaribe VC; Carvalho AMR; Rebouças MO; Macedo DS; Chaves Filho AJM; Fonteles MMF; Gutierrez SJC; Barbosa-Filho JM; Mottin M; Andrade CH; Sousa FCF
    Behav Brain Res; 2020 Apr; 383():112487. PubMed ID: 31987932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mechanism of action of antidepressant drugs: importance of genetically modified mice in the pharmacological in vivo approach].
    Gardier A
    Therapie; 2005; 60(5):469-76. PubMed ID: 16433012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mechanism of action of antidepressants and therapeutic perspectives].
    Bourin M; David DJ; Jolliet P; Gardier A
    Therapie; 2002; 57(4):385-96. PubMed ID: 12422559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidepressant properties of substance P antagonists: relationship to monoaminergic mechanisms?
    Adell A
    Curr Drug Targets CNS Neurol Disord; 2004 Apr; 3(2):113-21. PubMed ID: 15078186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoamine neurocircuitry in depression and strategies for new treatments.
    Hamon M; Blier P
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():54-63. PubMed ID: 23602950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular and cellular mechanisms of antidepressant drugs.
    Owens MJ
    Depress Anxiety; 1996-1997; 4(4):153-9. PubMed ID: 9166647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin/dopamine interaction--focus on 5-HT2C receptor, a new target of psychotropic drugs.
    Di Giovanni G; Di Matteo V; Esposito E
    Indian J Exp Biol; 2002 Dec; 40(12):1344-52. PubMed ID: 12974395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin1B heteroreceptor activation induces an antidepressant-like effect in mice with an alteration of the serotonergic system.
    Chenu F; David DJ; Leroux-Nicollet I; Le Maître E; Gardier AM; Bourin M
    J Psychiatry Neurosci; 2008 Nov; 33(6):541-50. PubMed ID: 18982177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The importance of brain serotonergic receptor mechanisms for the action of antidepressant drugs.
    Ogren SO; Fuxe K; Agnati L
    Pharmacopsychiatry; 1985 Mar; 18(2):209-13. PubMed ID: 3927330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin autoreceptor function and antidepressant drug action.
    Hjorth S; Bengtsson HJ; Kullberg A; Carlzon D; Peilot H; Auerbach SB
    J Psychopharmacol; 2000 Jun; 14(2):177-85. PubMed ID: 10890313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of antidepressant treatment on serotonergic and dopaminergic systems in Fawn-Hooded rats: a quantitative autoradiography study.
    Chen F; Lawrence AJ
    Brain Res; 2003 Jun; 976(1):22-9. PubMed ID: 12763618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent pharmacologic advances in antidepressant therapy.
    Kilts CD
    Am J Med; 1994 Dec; 97(6A):3S-12S. PubMed ID: 7992824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Galanin receptor antagonists : a potential novel pharmacological treatment for mood disorders.
    Ogren SO; Kuteeva E; Hökfelt T; Kehr J
    CNS Drugs; 2006; 20(8):633-54. PubMed ID: 16863269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurobiological mechanisms involved in antidepressant therapies.
    Briley M; Moret C
    Clin Neuropharmacol; 1993 Oct; 16(5):387-400. PubMed ID: 8221701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidepressants and serotonergic neurotransmission: an integrative review.
    Willner P
    Psychopharmacology (Berl); 1985; 85(4):387-404. PubMed ID: 2410942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central pre- and postsynaptic 5-HT1A receptors in rats treated chronically with a novel antidepressant, cericlamine.
    Jolas T; Haj-Dahmane S; Kidd EJ; Langlois X; Lanfumey L; Fattaccini CM; Vantalon V; Laporte AM; Adrien J; Gozlan H
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1432-43. PubMed ID: 8138956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A role for 5-HT in the action of antidepressant drugs.
    Cowen PJ
    Pharmacol Ther; 1990; 46(1):43-51. PubMed ID: 2181490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.